[Pharmacological treatment of delusional depression].

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Minerva Psichiatrica

• Publication date

  1996-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 8804200
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• A revisionist model for treatment-resistant and difficult-to-treat depression

  2024cites this paper
• A System for Rapidly Yet Rigorously Evaluating the Quality of Randomized Controlled Trials

  2023cites this paper
• Antidepressant and antipsychotic treatment of Psychotic Major Depression in a British mental healthcare setting

  2021cites this paper
• Management of major depressive disorder with psychotic features

  2021cites this paper
• Em.ergency treabnent of depression

  2017cites this paper
• Targeting and transforming major depression

  2017cites this paper
• The best drug treatment for psychotic depression: Antidepressants, antipsychotics or both combined? Commentary On… Cochrane Corner

  2017cites this paper
• Die wahnhafte Depression

  2016cites this paper
• Rating scales measuring the severity of psychotic depression

  2015influential citation
• Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

  2015cites this paper
• Perphenazine, amitriptyline and perphenazine-amitriptyline: role in clinical practice

  2014cites this paper
• Measuring psychotic depression

  2014cites this paper
• Perfenazina, amitriptilina e perfenazina-amitriptilina: ruolo nella pratica clinica Perphenazine, amitriptyline and perphenazine-amitriptyline: role in clinical practice

  2014cites this paper
• Measuring treatment response in psychotic depression: the Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account.

  2014cites this paper
• The DSM‐5 classification of mood disorders: some fallacies and fault lines

  2014cites this paper
• An expert panel review of clinical challenges in psychiatry AUGMENTATION STRATEGIES FOR DEPRESSION : HISTORY AND CONCEPTS

  2013cites this paper
• The treatment of psychotic depression: is there consensus among guidelines and psychiatrists?

  2013cites this paper
• A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures.

  2013cites this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders

  2013influential citation
• Challenges in the treatment of major depressive disorder with psychotic features.

  2013cites this paper
• An Update on Psychotic Depression

  2012cites this paper
• Considerations on the ICD-11 Classification of Psychotic Depression

  2012cites this paper
• Combined Venlafaxine and Olanzapine Prescription in Women with Psychotic Major Depression: A Case Series

  2011cites this paper
• Le modèle de l'attachement adulte dans la perturbation de la régulation émotionnelle et des liens affectifs des femmes hospitalisées souffrant de dépression

  2011cites this paper
• Psychotische Depression: Unterscheidungsmerkmale zur nicht-psychotischen Depression

  2011cites this paper
• Treatment of unipolar psychotic depression: a randomized, double‐blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine

  2010cites this paper
• [Review of the guidelines of the Brazilian Medical Association for the treatment of depression (Complete version)].

  2009cites this paper
• Treatment of unipolar psychotic depression: The use of evidence in practice guidelines

  2009influential citation
• Review of the guidelines of the Brazilian Medical Association for the treatment of depression ( Full version )

  2009cites this paper
• Electroconvulsive Therapy in Late-Life Depression

  2009cites this paper
• [Guidelines of the Brazilian Medical Association for the treatment of depression (complete version)].

  2009cites this paper
• A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD).

  2009cites this paper
• The under-recognized role of dopamine in the treatment of major depressive disorder.

  2008cites this paper
• Biologische behandlung unipolarer depressiver störungen in der allgemeinärztlichen versorgung: Leitlinien der World Federation of Societies of Biological Psychiatry (WFSBP)

  2008cites this paper
• The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An Update on Psychotic Depression

  2008cites this paper
• Revised psychopharmacological algorithms for the treatment of mood disorders in Japan

  2008cites this paper
• Efficacy of Imipramine in Psychotic Versus Nonpsychotic Depression

  2008cites this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care

  2007influential citation
• Polypharmacy: When Is It Rational?

  2007cites this paper
• Quality Indicators for the Care of Depression in Vulnerable Elders

  2007cites this paper
• Is the diagnosis of melancholia important in shaping clinical management?

  2007cites this paper
• Biologische Behandlung akuter depressiver Episoden

  2007cites this paper
• Defining melancholia: the primacy of psychomotor disturbance

  2007cites this paper
• Combination pharmacotherapy in unipolar depression

  2006cites this paper
• Background The optimal pharmacological treatmentof unipolar psychotic depression is uncertain. Aims To compare the clinical effectiveness of pharmacological treatments for patientswithunipolar

  2006influential citation
• Treatments in depression

  2006cites this paper
• Clinical and Biological Effects of Mifepristone Treatment for Psychotic Depression

  2006cites this paper
• Current and emerging somatic treatment strategies in psychotic major depression

  2006cites this paper
• Tardive dyskinesia and antipsychotics: a 5-year longitudinal study of frequency, correlates and course

  2006cites this paper
• Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression.

  2006cites this paper
• Depressive subtypes and efficacy of antidepressive pharmacotherapy

  2005cites this paper
• Evidence-based pharmacologic interventions for geriatric depression.

  2005cites this paper
• The pharmacological management of depression

  2005cites this paper
• Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or antidepressants

  2005cites this paper
• State of the science on psychosocial interventions for ethnic minorities.

  2005cites this paper
• Predictors of remission after electroconvulsive therapy in unipolar major depression.

  2005cites this paper
• Marked effect of milnacipran combined with olanzapine for a delusional depressive patient

  2005cites this paper
• Mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features: Trouble at the borders

  2005cites this paper
• Mixed depressive states: Nosologic and therapeutic issues

  2005cites this paper
• Antidepressant Treatment of Psychotic Major Depression: Potential Role of the σ Receptor

  2005cites this paper
• Structural and functional models of depression: from sub‐types to substrates

  2005cites this paper
• Modelling and Managing the Depressive Disorders: A Clinical Guide

  2005cites this paper
• Depression und Suizid: Sind antidepressive Therapien bei der Akut- und Langzeittherapie uni- und bipolarer affektiver Erkrankungen suizidpräventiv?

  2005cites this paper
• The Inhibitory Effect of Amoxapine on Cytochrome P450 Enzyme Activity in Human Liver Microsomes

  2004cites this paper
• Australian and New Zealand Clinical Practice Guidelines for the Treatment of Depression

  2004cites this paper
• A Double-Blind, Randomized Study of Olanzapine and Olanzapine/Fluoxetine Combination for Major Depression With Psychotic Features

  2004cites this paper
• Tratamiento de la depresión psicótica

  2004cites this paper
• Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder.

  2004cites this paper
• Clinical and phenomenological comparisons of delusional and non‐delusional major depression in the Chinese elderly

  2003cites this paper
• Clinical Outcome after Trimipramine in Patients with Delusional Depression - a Pilot Study

  2003cites this paper
• Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms

  2003cites this paper
• New approaches to managing psychotic depression.

  2003cites this paper
• Nefazodone in Psychotic Unipolar and Bipolar Depression: A Retrospective Chart Analysis and Open Prospective Study on Its Efficacy and Safety versus Combined Treatment with Amitriptyline and Haloperidol

  2003cites this paper
• Label Trial of C-1073 ( Mifepristone ) for Psychotic Major Depression *

  2002influential citation
• Dépressions sévères, difficiles et résistantes : aspects cliniques et thérapeutiques Severe, difficult and resistant depressions: clinical and therapeutic aspects

  2002cites this paper
• Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis.

  2002cites this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder

  2002cites this paper
• The definition and meaning of treatment-resistant depression.

  2001cites this paper
• The significance of delusions in depressive disorders

  2001cites this paper
• Switching antidepressants for treatment-resistant major depression.

  2001cites this paper
• Die effektivere Behandlung einer depressiven Störung mit psychotischen Symptomen durch Kombination mit Olanzapin

  2000cites this paper
• Psychotic Symptoms in Posttraumatic Stress Disorder

  2000cites this paper
• Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia.

  2000cites this paper
• The treatment of bipolar depression.

  2000cites this paper
• Dopamine and Depression

  2000cites this paper
• Psychotic Depression: What Is It and How Should We Treat It?

  2000cites this paper
• Psychotic features and illness severity in combat veterans with chronic posttraumatic stress disorder.

  1999cites this paper
• Antidepressant effectiveness in severe depression and melancholia.

  1999cites this paper
• Treatment-Resistant Depression

  1998cites this paper
• The treatment of psychotic depression.

  1998cites this paper
• Pharmacological management of treatment-resistant depression

  1998cites this paper
• Anticonvulsants and antipsychotics in the treatment of bipolar disorder.

  1998cites this paper
• Is There an Advantage to Venlafaxine in Comparison with Other Antidepressants?

  1997cites this paper
• Psychotic symptoms in mood disorders: evaluation of 159 inpatients

  1996cites this paper
• Late-Life Delusional Depression: Acute and Long-Term Treatment

  1995cites this paper
• Psychotic Depression

  year unknowncites this paper